Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-28

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental ANDA for a generic Dexmethylphenidate Hydrochloride product from Cranbury Pharmaceuticals, enabling market entry for this formul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)